Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Acute Lung Injury × pirfenidone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibroma, Plexiform 2 Squamous Cell Carcinoma of Head and Neck 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Nerve Sheath Neoplasms 1 Myofibroma 1 Lymphedema 1 Lung Neoplasms 1 Leiomyoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Acute Lung Injury 1

Interventions

pirfenidone 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05704166 2025-08-08

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

Fujian Medical University Union Hospital

Phase 2 Recruiting

Breast Neoplasms, Acute Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡